infectious-disease funding
50 open opportunities tagged infectious-disease, across federal agencies and private foundations. Sorted by deadline.
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
S. technology development and commercialization.
6 review criteria on fileSBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
S. technology development and commercialization.
7 review criteria on fileARMY ARM26BX03-NP006 — xTech|Inversion Competition
S.S.
3 review criteria on fileAnimal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
Objective ORIP uses the P40 mechanism to support Animal and Biological Material Resource Centers in a variety of areas of biomedical science.
9 review criteria on filePlant Protection Act Section 7721 Plant Pest and Disease Management and Disaster Prevention Program (PPDMDPP)
This funding opportunity is provided to carry out the provisions described in Section 7721 of the Plant Protection Act .
Review criteria on fileDTRA DTR26TZ05-NP001 — Novel Technologies for CWMD and Related Threats
Develop novel technologies with commercial and national security applications that enable the detection (or indication and warning) of radiological or nuclear threats without the need for bespoke sensors—using only signals from general-purpose military hardware, commercially-available devices proliferate in civil society, and…
3 review criteria on fileUSAF DAF26BZ05-NV029 — Cost-Effective Composite Joints with Tailorable Performance and Geometry
The technology within this topic is restricted under the International Traffic in Arms Regulation (ITAR), 22 CFR Parts 120-130, which controls the export and import of defense-related material and services, including export of sensitive technical data, or the Export Administration Regulation (EAR), 15 CFR Parts 730-774, which controls…
3 review criteria on fileDTRA DTR26BZ05-NP001 — Novel Technologies for CWMD and Related Threats
Develop novel technologies with commercial and national security applications that enable the detection (or indication and warning) of radiological or nuclear threats without the need for bespoke sensors—using only signals from general-purpose military hardware, commercially-available devices proliferate in civil society, and…
3 review criteria on fileAtopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
Research Objectives Atopic Dermatitis (AD) is a chronic inflammatory pruritic skin disease that affects approximately 11% of children and up to 9% of adults in the United States.
13 review criteria on fileNIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Background The mission of the National Institute of Allergy and Infectious Diseases (NIAID) is to conduct and support basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.
13 review criteria on fileSpecialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE).
5 review criteria on fileAvant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
The National Institute on Drug Abuse (NIDA) Avant-Garde and Avenir Awards Program for HIV Research supports exceptionally creative scientists, who propose high-impact studies that open new areas of HIV research in the context of substance use and Substance Use Disorders (SUD) and/or lead to new avenues for HIV prevention, treatment and…
7 review criteria on fileNIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Background The mission of the National Institute of Allergy and Infectious Diseases (NIAID) is to conduct and support basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.
7 review criteria on fileLimited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-18-669 that support Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) research.
5 review criteria on fileResource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
Experimental research models are indispensable for studying the genetic basis and pathobiological mechanisms underlying human diseases, identifying drug targets, and developing effective preventive and therapeutic approaches.
7 review criteria on fileSingle Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from an eligible organization to apply. Please see Section III.
7 review criteria on fileLimited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)
Purpose This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III.
17 review criteria on fileNIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants designed to advance the diagnosis, prevention, treatment, and amelioration of human sensory and communication disorders.
8 review criteria on fileCausal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)
6 years.25 billion fewer life years for the United States population.
3 review criteria on filePriority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that aligns with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR).
3 review criteria on fileEarly Immune System Development and Ontogeny (R01 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to further elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).
3 review criteria on fileNational Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is soliciting research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM.
4 review criteria on fileNIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Background Clinical trials are one strategy NIAID uses to improve prevention, diagnosis, and treatment of infectious, immunologic, and allergic diseases in addition to understanding the mechanisms of these diseases.
3 review criteria on fileTranslational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
The Ultra-Rare Gene-Based Therapy (URGenT) network supports Investigational New Drug (IND)-enabling studies and planning activities for First-in-Human (FIH) clinical testing of gene-based or transcript-directed therapeutics, such as oligonucleotides and viral-based gene therapies, for ultra-rare neurological or neuromuscular disorders.
3 review criteria on fileContinuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
Cardiovascular complications remain the leading cause of death among individuals with T1D despite the management of traditional risk factors such as high blood glucose, high blood pressure, and elevated cholesterol.
3 review criteria on fileScience Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
The Science Track Award for Research Transition (START) programs have been key initiatives of the National Institute on Drug Abuse (NIDA).
3 review criteria on filePilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities.
3 review criteria on fileDevelopment and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions.
3 review criteria on filePlant Protection Act Section 7721 Fiscal Year 2027 National Clean Plant Network (NCPN)
S. Department of Agriculture, Animal and Plant Health Inspection Service announce this funding opportunity to carry out the Plant Protection Act Section 7721 (PPA 7721) National Clean Plant Network (NCPN) program.
Review criteria on fileHEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Background: The NIH HEAL Initiative: This NOFO encourages applications in support of the NIH's Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis.
3 review criteria on fileUsing Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
The secondary use of archived data and/or biospecimen collections represents a critical opportunity to advance research in maternal, pediatric, and adolescent HIV. These resources enable investigators to validate prior findings, address novel hypotheses, and generate insights that extend beyond the scope of the original studies.
3 review criteria on fileNational Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
The purpose of this notice of funding opportunity (NOFO) is to accelerate innovative drug and device therapies translation from discovery to early human studies.
3 review criteria on filePopulation Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
S.gov/research/nida-research-programs-activities/population-assessment-tobacco-health-path-study/data-access ).
Review criteria on fileAccelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
The purpose of this notice of funding opportunity (NOFO) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related…
3 review criteria on fileAccelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
The purpose of this notice of funding opportunity (NOFO) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related…
3 review criteria on fileARMY ARM26BX03-DP007 — xTech|Kinetic Reach Competition
S.S.
3 review criteria on fileTitle X Family Planning Services Grants
C.S.
Review criteria on fileDevelopment of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
The NIH Office of Research Infrastructure Programs (ORIP) administers two extramural construction programs: the Biomedical Research Facilities (BRF) program and the HIV/AIDS Research Facilities (HRF) program.
5 review criteria on fileDiabetes Research Centers (P30 Clinical Trial Optional)
Background According to the CDC, the prevalence of diabetes mellitus in the United States continues to rise over time.6% of the US Population) and about twice that prevalence in those over 65.
9 review criteria on fileHigh Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
The purpose of this notice of funding opportunity (NOFO) is to support high priority research at the intersection of HIV and substance use.
3 review criteria on fileHigh Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
The purpose of this notice of funding opportunity (NOFO) is to support high priority research at the intersection of HIV and substance use.
Review criteria on fileNARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats.
7 review criteria on fileBRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) from the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is intended to support facilities at Resource-Limited Institutions (RLIs) and Institutional Development Award (IDeA)-eligible institutions for scaled production and distribution of brain cell…
6 review criteria on fileDepartment of Defense HIV/AIDS Prevention Program
ATTENTION: This announcement will be revised regularly to incorporate country specific narratives (Attachment 1 of the announcement) with information vital to the content of application. Potential applicants interested in applying to this announcement should click 'Subscribe' to be notified of future revisions.
Review criteria on fileAnimal and Veterinary Innovation Centers (U18)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for inclusion as Animal and Veterinary Innovation Centers, which are intended to form long-term partnerships to address priority areas for FDA's Center for Veterinary Medicine (CVM).
Review criteria on fileVet-LIRN Capacity-Building Project and Equipment Grants (U18)
The goal of this NOFO is to fund veterinary diagnostic laboratories in the Vet-LIRN network for grants associated with projects and equipment. Specific objectives include: 1.
Open Philanthropy — Announcing the Strep A Vaccine Fund
Announcing the Strep A Vaccine Fund | Coefficient Giving Skip to Content Coefficient Giving Research / Announcements May 26, 2026 Announcing the Strep A Vaccine Fund By Alexander Berger and Katharine Collins Most people in wealthy countries know Strep A as the cause of strep throat, an uncomfortable but easily treated childhood illness.
Biosensing
The Biosensing program is part of the Engineering Biology and Health cluster, which also includes 1) the Biophotonics program; 2) the Cellular and Biochemical Engineering program; 3) the Disability and Rehabilitation Engineering program; and 4) the Engineering of Biomedical Systems program.
2 review criteria on file · agency frameworkEngineering of Biomedical Systems
TheEngineering of Biomedical Systemsprogram is part of the Engineering Biology and Health cluster, which also includes: 1) theBiophotonicsprogram; 2) theBiosensingprogram; 3) theCellular and Biochemical Engineeringprogram; and 4) theDisability and Rehabilitation Engineeringprogram.
2 review criteria on file · agency frameworkPlant Biotic Interactions
The Plant Biotic Interactions (PBI) program supports research on the processes that mediate beneficial and antagonistic interactions between plants and their viral, bacterial, oomycete, fungal, plant, and invertebrate symbionts, pathogens and pests.
2 review criteria on file · agency frameworkSee which infectious-disease opportunities fit your work
An account is free and shows the full announcement, the review criteria reviewers score you against, and whether you are actually eligible — including the windows that close before the deadline does.
No card required.